カンナビジオール (CBD)

Cannabidiol, more commonly known as CBD, is a non- psychoactive compound found in the cannabis plant.
It is becoming increasingly popular due to its many potential therapeutic uses (e.g. epilepsy, pain and inflammation).

CBD works by interacting with the body’s endocannabinoid system, which is responsible for regulating many of the body’s functions, including mood, appetite, sleep, and more.

Indena uses registered varieties of Cannabis sativa with a THC level of less than 0.2% in accordance with European standards.
It also guarantees a residual THC content of less than 0.02%, well below the limits defined by the FDA (Food and Drug Administration) and by DEA (Drug Enforcement Administration).

This approach enabled Indena to promptly submit the DMF (Drug Master File) for this product to the FDA.
The biomass is processed at Indena’s pharmaceutical plant, regularly authorised by AIFA, inspected by the main international regulatory agencies (FDA, KFDA, PMDA and others) and ISO14001 Certified.

All production is carried out in compliance with pharmaceutical GMP (Good Manufacturing Practices), in line with the highest quality standards that the company has always applied which have been recognised by the international scientific community and consolidated over 100 years of business.